1. |
中华人民共和国卫生部. 黑热病诊断标准: WS 258-2006, 2006.
|
2. |
Lun ZR, Wu MS, Chen YF, et al. Visceral leishmaniasis in China: an endemic disease under control. Clin Microbiol Rev, 2015, 28(4): 987-1004.
|
3. |
《中华传染病杂志》编辑委员会. 中国利什曼原虫感染诊断和治疗专家共识. 中华传染病杂志, 2017, 35(9): 513-518.
|
4. |
Badiola J, Muñoz-Medina L, Callejas JL, et al. Hemophagocytic lymphohistiocytosis associated with Leishmania: a hidden passenger in endemic areas. Enferm Infecc Microbiol Clin (Engl Ed), 2021, 39(4): 188-191.
|
5. |
Duan H, Li X, Mei A, et al. The diagnostic value of metagenomic next-generation sequencing in infectious diseases. BMC Infect Dis, 2021, 21(1): 62.
|
6. |
Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin infect dis, 2018, 67(Suppl 2): S231-S240.
|
7. |
Li N, Cai Q, Miao Q, et al. High-throughput metagenomics for identification of pathogens in the clinical settings. Small methods, 2021, 5(1): 2000792.
|
8. |
Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med, 2007, 357(25): 2601-2614.
|
9. |
Chen H, Fan C, Gao H, et al. Leishmaniasis diagnosis via metagenomic next-generation sequencing. Front Cell Infect Microbiol, 2020, 10: 528884.
|
10. |
van Griensven J, Diro E, Lopez-Velez R, et al. HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals. Lancet Infect Dis, 2013, 13(3): 251-259.
|
11. |
Goldberg B, Sichtig H, Geyer C, et al. Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics. mBio, 2015, 6(6): e01888-15.
|
12. |
Mitchell SL, Simner PJ. Next-generation sequencing in clinical microbiology: are we there yet?. Clin Lab Med, 2019, 39(3): 405-418.
|
13. |
Li N, Li S, Tan W, et al. Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19. Emerg Microbes Infect, 2021, 10(1): 1418-1428.
|